NL-OMON39246招募中不适用
PANDA trial: PAncreatic Neoplasms and Drainage After surgery - PANDA trail
Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 360 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 360
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Diagnosis of pancreas head tumour
- •- Elective Pancreaticoduodenectomy
- •- Age > 18 years
- •- ASA I / II / III
- •- Written informed consent
排除标准
- •- Emergency surgery
- •- ASA IV / V
- •- Impossibility to obtain informed consent
- •- Pregnancy
研究者
相似试验
进行中（未招募）
1 期
ocally Advanced Pancreatic Cancer: Phase II study of cetuximab and 3-D conformal image-guided radiotherapy (PACER Study) - PACER StudyEUCTR2006-001742-13-GBChristie Hospital NHS Trust44
招募中
2 期
PAT-07Borderline resectable pancreatic cancerBorderline resectable, pancreatic cancerD021441JPRN-jRCTs041200028Kodera Yasuhiro50
招募中
不适用
PanDPI-Study (pancreatic carcinoma) and CoRDPI-Study (colorectal cancer)C25C18C20C78.7Malignant neoplasm of pancreasMalignant neoplasm of colonMalignant neoplasm of rectumSecondary malignant neoplasm of liver and intrahepatic bile ductDRKS00031431Klinik am See300
终止
1 期
Investigation of gemcitabine combined with temsirolimus, in patients with inoperable or metastatic pancreatic cancer. A phase I-II study by the Hellenic Cooperative Oncology Group with biomarker evaluation (HE3/07)Patients with inoperable or metastatic pancreatic cancerCancer - PancreaticACTRN12611000643976Hellenic Cooperative Oncology Group85
招募中
2 期
agoya University Pancreatic Tumor Board trial 08ocally advanced pancreatic cancerJPRN-jRCTs041200054Kodera Yasuhiro50